Malaria in Pregnancy Clinical Trial
Official title:
Effectiveness of Intermittent Screening and Treatment of Malaria in Pregnancy (ISTp) on Maternal and Birth Outcomes in Selected Districts in Rwanda
The main aim of this study is to test the primary hypothesis that the addition of intermittent screening and treatment of malaria in pregnant women (ISTp) who receive routine antenatal care (ANC) in health facilities in high malaria transmission areas in Rwanda will reduce malaria prevalence among pregnant women when compared to routine antenatal cares services alone.
More specifically, the primary objective is to understand the effect of ISTp in a context
where routine antenatal care does not include malaria chemoprohylaxis and whether this
intervention is protective against malaria during pregnancy. The secondary objective is to
determine whether this intervention results in an improvement in other key maternal and
newborn health outcomes including maternal anemia, low birth weight and prematurity. The
third objective is to determine the feasibility, effectiveness and acceptability of ISTp
among women who receive ISTp and among health workers who deliver this intervention.
This study will establish if testing and treating pregnant women is effective, feasible and
whether it adds an additional burden to the work already being undertaken by facility-based
health workers who provide antenatal care services. It is expected that the study will result
in information to develop appropriate approaches that can be implemented in Rwanda in the
prevention of malaria in pregnancy in addition to the use of preventive measures such as
insecticide treated mosquito nets (ITNs) and case management. This information may
potentially also be used by other countries with similar patterns of malaria transmission.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01053325 -
Establishing Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in Pregnancy
|
Phase 3 | |
Completed |
NCT00140517 -
Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance
|
N/A | |
Recruiting |
NCT05306067 -
Plasmodium Falciparum Genomic Intelligence in Mozambique
|
||
Recruiting |
NCT05757167 -
Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics
|
Phase 4 | |
Active, not recruiting |
NCT01555255 -
Malaria Rapid Diagnostic Tests (RDTs) in Pregnancy: Detection of Placental Malaria
|
N/A | |
Completed |
NCT01136850 -
Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea
|
Phase 3 | |
Terminated |
NCT04148690 -
Assessing the Impact of Group Antenatal Care on IPTp Uptake in Tanzania
|
N/A | |
Completed |
NCT04160026 -
Acceptability and Feasibility in the Context of the IMPROVE Trial in Kenya
|
Phase 4 | |
Completed |
NCT04783051 -
Comparison of ISTp- PYRAMAX-US-RDT to IPTp-SP to Prevent Malaria in Pregnant Women in DRC (ULTRAPYRAPREG)
|
Phase 3 | |
Not yet recruiting |
NCT05348746 -
ERASE - Impact of COVID-19 on Malaria Control
|
||
Completed |
NCT03998839 -
TIPTOP Sulfadoxine-pyrimethamine (SP) Drug Resistance Study
|
||
Completed |
NCT03208179 -
Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa
|
Phase 3 | |
Completed |
NCT01120145 -
Assessment of Sulphadoxine-pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Malawi
|
N/A | |
Completed |
NCT00730366 -
New Approaches to Improve Coverage and Compliance of Antimalarial Treatment for Pregnant Women in Rural Africa
|
Phase 3 | |
Completed |
NCT00852423 -
Safe and Efficacious Artemisinin-based Combination Treatments for African Pregnant Women With Malaria
|
Phase 3 | |
Completed |
NCT00680732 -
Prevention of Intrauterine Growth Retardation in Burkina Faso: the Malaria Component
|
Phase 4 | |
Recruiting |
NCT03754322 -
LAMP Detection of Malaria in PREGnancy (LAMPREG) Trial
|
N/A | |
Not yet recruiting |
NCT03944317 -
Azithromycin (AZ) and Sulphadoxine-pyrimethamine (SP) for Malaria Prevention in Pregnant Women (IPT-AZ/IPT-SP)
|
N/A | |
Completed |
NCT05294406 -
Intermittent Preventive Treatment With Dihydroartemisinin-piperaquine in Papua, Indonesia
|
Phase 4 | |
Recruiting |
NCT04825782 -
MiMBa Pregnancy Registry
|